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PhospholipidClostridium perfringens phospholipase C (CpPLC), also called α-toxin, is the main virulence factor for gas
gangrene in humans. The lipase activity serves the bacterium to generate lipid signals in the host eukaryotic cell,
and ultimately to degrade the host cellmembranes. Several previous reports indicated that CpPLCwas speciﬁc for
phosphatidylcholine and sphingomyelin. Molecular docking studies described in this paper predict favorable
interactions of the CpPLC active site with other phospholipids, e.g. phosphatidylethanolamine, phosphatidyli-
nositol and, to a lesser extent, phosphatidylglycerol. On the basis of these predictions, we have performed
experimental studies showingα-toxin to degrade all the phospholipidsmentioned above. Themolecular docking
data also provide an explanation for the observed lower activity of CpPCL on sphingomyelin as compared to the
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The protein α-toxin (CpPLC) is the key virulence determinant of
Clostridium perfringens gas gangrene. α-Toxin is a zinc metallopho-
spholipaseC [1]. It belongs to a groupof relatedbacterial phospholipases
C (Bacillus cereus PC-PLC or BcPLC, Clostridium bifermentans PLC or
CbPLC, Listeria monocytogenes PLC-B, and Clostridium novyi γ-toxin
among others) which contain essential zinc ions and are reversibly
inactivated by EDTA or o-phenanthroline [2–7]. From the structural
point of view the crystal structure reveals a 370-residue, two-domain
protein with the N-terminal domain composed of α-helices and the C-
terminal domain consisting mainly of β-sheet [8]. These domains are
joined by a ﬂexible linker that favors interactions between the adjacent
faces of the domains. Functionally,α-toxinmay have at least twomodes
of action. At high concentrations it degrades eukaryotic cell membranes
helping in the spread and growth of the bacterium. At low doses it
causes limited phospholipid hydrolysis, which in turn activates DAG-
and ceramide-mediated signal transduction pathways, leading to the
uncontrolled production of several intracellular mediators [9].
Some of the bacterial phospholipases C (PLC) (sometimes referred
to as PC-speciﬁc phospholipases C) are active toward PC and show a
lower activity toward other phospholipids [2,10–12]. Activity of other
phospholipases C (termed PI-speciﬁc phospholipases C) is optimal on
Fig. 1. Stereo picture of Bacillus cereus phosphatidylcholine-preferring phospholipase C
(gray) and α-toxin (black). (A) Protein whole structure superposition. Spheres
represent zinc ions in the active site. (B) Protein active site superposition. Solely
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sphingomyelin as a substrate [14].
Martin and coworkers provided some new insights into the
molecular basis for substrate speciﬁcity in B. cereus PLC (BcPLC).
They identiﬁed several residues responsible for substrate speciﬁcity
using mutagenic, kinetic, and crystallographic experiments [15,16].
On the basis of site-directed mutagenesis of α-toxin and the
structure–function relationship of BcPLC, it was conﬁrmed that a
highly conserved motif, consisting of three zinc atoms that coordinate
residues including His, Glu, Asp and Trp, located in similar positions in
several members of the bacterial PLC family, is essential for the
catalytic activity [17]. Apart from Glu to Asp exchange, from BcPLC to
CpPLC respectively, the residues involved in the active site are
conserved [18]. The conserved motif in α-toxin is present in or near
the active site cleft of the N-domain and is essential for the hydrolytic
activity [8]. Despite the active domain of CpPLC showing 29%
sequence identity with BcPLC, their hydrolytic activity has been
reported to be quite different. While BcPLC is almost non-speciﬁc and
hydrolyses phospholipids in the order of preference: phosphatidyl-
choline (PC) Nphosphatidylethanolamine (PE) Nphosphatidylserine
(PS) [15,16], CpPLC is described to be speciﬁc for sphingomyelin (SM)
and PC. According to these studies α-toxin can bind and disrupt
artiﬁcial membranes (liposomes) composed of PC or SM but not of PS,
PE or phosphatidylglycerol (PG) [4,19].
Molecular docking is an important tool for computer-aided drug
design. This in silico technique can be used to calculate the three-
dimensional structure of a protein–ligand complex starting from the
individual structures of the constituent macromolecules. The crystal
structure of CpPLC with a lipid ligand is not known, but the structure of
BcPLC with a non-hydrolysable phospholipid has been deposited in the
protein data bank (PDB Accession No. 1P6D). Moreover there are a
number of important similarities with the non-speciﬁc BcPLC, namely
the CpPLC overall fold similarity (160 ca. atoms can be aligned with
a root-mean-square (r.m.s.) deviation of 1.49 Å), the 29% sequence
identity they share, and the presence in both PLCs of the highly
conserved motif mentioned above, located in a similar position in the
bacterial PLC family and essential for the catalytic activity [17]. Thus
BcPLC can be considered as a good template for docking experiments in
CpPLC (Fig. 1). Our results show that, in addition to PC and SM, other
phospholipids e.g. PE, PG and PI are also CpPCL ligands. Subsequent
experimental results conﬁrmed that these phospholipids are indeed
CpPLC substrates.aminoacid residues involved in the zinc coordination and phospholipid headgroup
interaction were taken into account.2. Materials and methods
2.1. Materials
Wild type recombinant C. perfringens α-toxin from strain 8–6
expressed in Escherichia coli was puriﬁed as described in Alape-Girón
et al. (2000) [20]. Tris ultrapure (Tris) was purchased from Apollo
Scientiﬁc, NaCl from Fluka and CaCl2 and ZnSO4 from Prolabo. Fatty
acid-free bovine serum albumin (BSA) was from Sigma. Egg-yolk
phosphatidylethanolamine (PE) was Grade 1 from Lipid Products, egg
sphingomyelin (SM), cholesterol (Chol), dioleoylphosphatidylcholine
(DOPC), dioleoylphosphatidylglycerol (DOPG), dioleoylphosphatidyl-
serine (DOPS) and liver phosphatidylinositol (PI) were supplied by
Avanti Polar Lipids (Alabaster, AL). The nature of the fatty acids from
egg SM, egg PE or liver PI is the following: egg SM (86% 16:0, 6% 18:0,
3% 22:0, 3% 24:1, 2% unknown), liver PI (46% 18:0, 8% 18:1, 6% 18:2,
13% 20:3, 17% 20:4, 10% unknown) and egg PE (22% 16:0, 37.4% 18:0,
29.4% 18:1, 11.2% 18:2).
Chloroform,methanol, hexane, sulfuric acid, cesiumethylenediamine-
tetra-acetate (EDTA-Cs) and silicagel plates (20×20 cm),werepurchased
fromMerck. Acetic acid and 37% hydrochloric acid were from Carlo Erba.
Deuterated chloroform (CDCl3-d) was purchased fromWilmad LabGlass.2.2. Methods
2.2.1. Docking computations
The automated docking tool chosen for this purpose was
AutoDock. This program allows automated docking of ﬂexible ligands
to proteins. It is very fast and provides high quality predictions of
ligand conformations. The program is based on a Lamarckian genetic
algorithm (LGA). Basically this program determines total interaction
energies between random pairs of a ligand and selected portions of a
protein to determine docking poses [21,22]. 3D structures used for
docking experiments were:
− Template- BcPLC (PDB ID 1P6D).
− Target- CpPLC (PDB ID 1CA1). We removed all water molecules
from the crystal structure, including those located in the binding
pocket.
− Ligands- PC, PE, PG, PI, PS and SM. We used the natural isomer of
the phospholipid (the R form) as the BcPLC-preferred isomer [23].
Since we were only interested in the protein-phospholipid head-
group interaction, 5-carbon acyl chains were used: D5PC, D5PE,
D5PG, D5PI, D5PS and 5SM (pentanoyl sphingomyelin).
1 Note in order to avoid misunderstandings: –Y57 is a CpPLC residue that interacts
with the phospholipid head group, it corresponds to Y56 in BcPLC. –Y65 is a CpPLC
residue that interacts with one of the ester linkages of the phospholipids but with the
amide linkage in SM, it corresponds to F66 in BcPLC.
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structures, following the program requirements [24]. Bonds of both
5C-acyl chains were turned into non-rotable bonds in order to reduce
computing time and focus our study on the lipid polar head group.
Protein preparation: In order to ensure the overall stereochemical
quality of the alpha-toxin and to show its local residue-by-residue
reliability, the structurewasevaluatedbyPROCHECK.91%of the residues
in the crystal structure of CpPLCwere found in themost favored regions
of the Ramachandran plot. Those residues in either generously allowed
or disallowed regions, respectively K80/N82/W84/Y88/S89/P295/N297
and F78/S79/S83/I90, were found to be located away from the active site
(Fig. S1).
Docking results and validation: Autodock predicts free energies
of binding in kcal/mol. We adopted the rigid-docking protocol.
Autodock generates a large number of duplicate poses within a RMSD
of 2 Å. Distances from the BcPLC crystal structure in complex with a
non-hydrolysable phospholipid (3)-3,4-di-n-hexanoyloxybutyl-1-
phosphocholine (PDB ID 1P6D), were used as reference (Fig. S2A).
It was found that the docked ligands were fairly superimposed with
the reference for the best-scored conformations. We considered the
best ranked to predict the binding mode of the ligand to the crystal
structure. Figures were generated with Pymol [25] and ADT [24].
2.2.2. Model membrane preparation
The appropriate lipids were mixed in chloroform:methanol (2:1, v/
v) and the solvents evaporated thoroughly. Multilamellar vesicles
(MLVs) were prepared by hydration of the lipid ﬁlm with buffer and
intensive vortexing. The suspension was frozen in liquid nitrogen and
thawed at 37 °C 10 times. Symmetric unilamellar vesicles (LUVs) were
prepared by the extrusionmethod described byNieva et al. (1989) [26].
Liposomes to be used in phospholipase and sphingomyelinase activity
assays were routinely prepared in buffer A (10 mM Tris, 0.9% w/v NaCl,
3 mM CaCl2, 0.005 mM ZnSO4, pH 7.5). For enzyme dilution buffer A′
was used (10 mM Tris, 0.9% w/v NaCl, 3 mM CaCl2, 0.005 mM ZnSO4,
0.1% w/v BSA, pH 7.5). For the DOPS-containing liposome preparation,
buffer Bwasused (10 mMTris–HCl, 0.9%w/vNaCl, 0.005 mMZnSO4) to
reach a 3 mM calcium concentration, prior to adding the protein.
2.2.3. CpPLC activity measurements
α-Toxin hydrolytic activity on different potential lipid substrates
was assayed by incubating 0.3 mM substrate (LUV) with enzyme in
1 ml buffer A [27,28]. 100 μl aliquots of the reaction mixture were
removed at pre-ﬁxed intervals, and added to 500 μl of a chloroform:
methanol:HCl mixture (66:33:1 vol ratio). The chloroform phase was
removed, evaporated and resuspended in 20 μl pure chloroform. The
sample was loaded onto a silicagel plate and run in a glass cuvette
with either chloroform:hexane:methanol:acetic acid (50:30:10:5 vol
ratio) for separation of DOPC, SM, DOPG and DOPE, or chloroform:
methanol:acetic acid:water (60:50:1:4 vol ratio) for separation of
DOPC, SM, DOPS and liver PI. Two different staining methods were
used, for preparative and analytical purposes respectively. For the
analytical stain the plate was dried and treated with sulfuric acid (5%
v/v) and heated for 10 min at 110 °C. The spots were quantiﬁed with a
Bio-Rad G800 densitometer and the data processedwith Quantity One
(Bio-Rad, U.K.). For the preparative stain the plates were dried and
stained with iodine salts. The spots were scraped off and the lipid
extracted with a chloroform:methanol (2:1) solution.
Quantitative 31-phosphorus NMR (31P-NMR) was used to conﬁrm
the differential hydrolysis of various substrates without separation of
reaction products. 5 mM LUV in buffer A was mixed with the protein,
previously diluted in buffer A′ and incubated for 5 min at 37 °C. 1 ml
aliquots of the reaction mixture were added at ﬁxed intervals to 5 ml
of a chloroform:methanol:HCl mixture (66:33:1 vol. ratio). After
phase separation, the aqueous or upper phase was removed and
DOPG was added to the chlorophorm phase as a quantiﬁcation
standard. Then the solvents from the chloroform lower phase wereevaporated thoroughly. The lipid ﬁlm was resuspended in 750 μl of
CDCl3-d:methanol:200 mM EDTA-Cs (10:4:1 vol ratio) and then
transferred to 5-mm NMR tubes. Data acquisition was performed in
a Bruker AV500 spectrometer (Rheinstetten, Germany) operating at
202.4 MHz for P, with a 5-mmwide-band probe and a gradient in the
Z-axis, at 25 °C. The experiments were performed with the zgig
sequence (Bruker) and a delay time of 15 s between scans. Data were
processed with a 1 Hz exponential factor [29,30].3. Results
3.1. Computational studies
Residues E4, A3, Y56 and F66 were described to be important for
phospholipid head group interactionwith BcPLC (Fig. S2A) [15]. First a
control docking experiment was run to determine the reliability of
the program. We docked the non-hydrolysable ligand (3)-3,4-di-n-
hexanoyloxybutyl-1-phosphocholine (DHPC) from PDB ID 1P6D into
the active site of BcPLC and compared the result with the crystal
structure. From the resulting docked model, the ligand has equivalent
distances (see Table 1) and structure as compared to the template
with the exception of the phosphate group (P-group) being buried
0.5 Å deeper into the active site (Fig. S2B). Attempts to keep water
molecules in the active site that might be involved in the hydrolysis of
the ester linkage led to unreasonable results. Moreover, the
conformation of the docked ligand shows only slight differences in
the acyl chains as compared to the template (Fig. S2B). In fact, when
comparing the structures of the BcPLC protein crystallized with two
different non-hydrolysable ligands (PDB ID 1P6D and 1P6E), the
position of the phosphate group does not change even though the
active site allows different conformations for the head group and acyl
chains (Fig. S2C). We therefore required the docking solutions to
reproduce the P-group/protein interaction, given the strong resem-
blance of the non-hydrolysable substrate docked structure in the
BcPLC active site and the crystal structure from 1P6D.
Special attention was given to the position of the phosphate group
and the distances between it and the CpPLC hydrolytic residues D56
and D130 (corresponding to D55 and D122 in BcPLC, respectively),
the Zn ions and the residues that coordinate with the three Zn ions as
they are essential for protein activity.
Firstwe docked a D5PCmolecule in the active site of CpPLC. Residues
D2, G3 and Y57 interactwith the lipid head group in agreementwith our
template (Fig. 2A). Asp and Tyr keep similar distances to the choline
moiety of the phospholipid, 3.91 Å and 4.30 Å respectively (less than
0.5 Å difference from the template) (Table 1). A3 in the template is quite
far fromtheheadgroup (6.1 Å), but inourdocking results (it corresponds
to G3) it is situated about 2 Å closer and is participating in the
phospholipid headgroup interaction. The distances between the
aminoacids responsible for phosphodiester linkage cleavage (D55 and
D122 inBcPLC vs. D56 andD130 inCpPLC) and the phosphate differ from
the template by less than 0.5 Å. Moreover, the dihedral angles showed a
maximum difference of 4° to the template. These minimal differences
can be attributed to the absence of water in the protein active site.
When the ligand is 5SM, despite having the same headgroup as PC,
this phospholipid has a ceramide backbone instead of diacylglycerol.
The amide linkage fromceramide interactswith residueY65 responsible
of ester linkage interaction in glycerophospholipids. However, residue
Y57 is not involved in the interaction with the choline moiety (Fig. 2B)
which might cause a lower afﬁnity of CpPLC for SM than for PC, in
agreement with the experimental data from Urbina et al. [27,28]. 1
Table 1
Docking results. List of distances in Å from docking results. Template distances in gray.
Distances (Å) Distances (Å)
Residues Template (PcPLC-DHPC)
(PDB ID 1P6D)
Control (PcPLC-DHPC) Residues CpPLC-D5PC CpPLC-5SM CpPLC-D5PE CpPLC-D5PG CpPLC-D5PI
A3 — choline 6.10 5.95 G3 — choline 4.10 4.75 4.7⁎ – 2.58#
E4 O1 — choline 3.99 3.84 D2 O1 — choline 3.91 3.62 2.7⁎ – 2.7#
E4 O2 — choline 4.83 4.74 D2 O2 — choline 5.28 5.07 4.1⁎ – –
Y56 — choline 4.57 4.47 Y57 — choline 4.30 – – – 3.18#
N55 O1 — P-group 3.78 3.76 D56 O1 — P-group 4.07 3.92 4.10 3.90 4.0
N55 O2 — P-group 3.60 3.56 D56 O2 — P-group 3.77 3.56 3.70 3.54 3.69
D122 O1 — P-group 3.90 3.42 D130 O1 — P-group 4.07 3.57 3.70 3.84 3.92
D122 O2 — P-group 4.07 3.72 D130 O2 — P-group 3.70 3.79 3.40 4.00 4.05
–, No distances measured.
⁎ Distances to ethanolamine headgroup.
# Distances to closest hydroxyl groups from D5PG polar headgroup.
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the cavity.While D2 andG3 are still required to stabilize the headgroup,
Y57 appears to have no role in the interaction with the ligand (Fig. 2C),
in agreement with the mutagenesis results obtained with BcPLC where
Y56 was not found to be necessary for interaction with PE [15,16].
Docking results from D5PE in CpPLC show shorter distances for the
headgroup-interacting residues (up to 2 Å difference for D2) due to the
unmethylated state of the PE amino group (Table 1). The cleavage site
remains in the same position, due to the electronegativity of the
phosphate group. The three zinc atomsattract the lipid phosphate group
and stabilize it in order to keep the cleavage site accessible to the
catalytic residues D56 and D130. The conformation of the phospholipid
is almost the same as in the template (less than 0.5 Å r.m.s.), adding to
the reliability of the results. In fact, dihedral angles between theD56 and
D130 side chain oxygens and the phosphate group reveal no signiﬁcant
differences.
When phosphorylglycerol is the polar headgroup of the ligand, it is
found to establish further hydrogen bridges with residue D56 of the
macromolecule. G3 and Y57 are not required anymore to interact with
the phospholipid. D2 is required for PG interaction according to our
docking results (Fig. 2D). Besides this, D56 takes part in the headgroup
interaction through a hydrogen bridge and no longer interacts with
the phosphate group (Fig. 2D). The D5PG head and phosphate groups
compete to interact with D56, which could explain the lack of
enzymatic activity against these phospholipids [4,19]. Despite the
phosphate group being found in the same position as in the template,
the dihedral angles differ by up to 18°, which might also decrease the
enzyme activity.
The inositol headgroup in the D5PI ligand can also establish
additional hydrogen bridges with the interacting residues. To accom-
modate the inositol headgroup, D2, G3 and Y57 establish electrostatic
interactions including hydrogen bridges with D2 and G3 (Fig. 2E). These
interactions shorten thedistances between these residues and the ligand
as compared with the template (2.7 Å for D2, 2.58 Å for G3 and 3.18 Å
for Y57), see Table 1. Ligand conformation is very similar to that of the
template. All dihedral angles showed little difference with the template
(b3°). As for theD5PE ligand, theD5PI docking results suggest that PI is a
good CpPLC substrate candidate.
Although D5PS is known to be a substrate for BcPLC [15,16], our
docking results showed a competition between the carboxyl and
phosphate moieties of the D5PS head group, leading to inconclusive
data on whether D5PS is a substrate candidate for CpPLC.
In summary, in all docking experiments (D5PS excepted) the same
residues (D2, G3 and Y57) are involved in lipid headgroup interaction,
and the dihedral angles of the catalytic residues with the phosphate
group show in most cases little difference with the template. When the
phospholipid has a large headgroup (PC, SM, PI), residues D2, G3 and
Y57 accommodate the phospholipid headgroup, but when this head-
group is relatively small (PG, PE), Y57 does not seem to be necessary forthe interaction. No major differences were detected for any of the
phospholipids tested as compared to the template. Furthermore, the
assigned correspondence between the aminoacid residues of CpPLC and
the template was also conﬁrmed by our docking results. The strong
similarity between BcPLC and CpPLC suggests that the latter might not
be as speciﬁc as it has been described to be in the literature [4,9,31].
3.2. Experimental studies
In order to verify the docking data, enzyme activities were assayed
on model membranes (LUV) of different lipid compositions.
3.2.1. Phosphatidylcholine, sphingomyelin and phosphatidylethanolamin
Our previous data had shown that CpPLC is able to hydrolyse PC and
SM in liposomes [27]. We tested the CpPLC activity on different lipid
mixtures of PC (or SM) and PE that were previously shown to support a
measurable activity [28], but we searched speciﬁcally for the hydrolysis
of the individual phospholipids in the mixture. We assayed the α-toxin
PLC activity on liposomes composed of DOPC:PE and DOPC:PE:Chol
respectively at 2:1 and 2:1:1 M ratios in buffer A at pH 5, at 37 °C and
20 ng/ml toxin. pH 5 was used because previous measurements had
shown thatα-toxinPLC activity onPCwasoptimumat this value [27]. At
different times, the reaction was stopped and an aliquot of the reaction
mixture was lipid-extracted and loaded onto a silicagel plate and
separated as indicated under Methods. After plate staining with
sulphuric acid the spots were quantiﬁed (Fig. 3). For the phospholipid
amounts in our assays (0 to 30 nmol), a linear relationship was found
between lipid amount and intensity of the spot for every phospholipid
quantiﬁed.
In the ﬁrst stages of the assay (after 10 min) the enzyme hydrolyses
more DOPC than PE but at later stages the trend is reversed both in the
presence and absence of Chol. Comparing Fig. 3A and B shows that Chol
activates α-toxin as observed previously [28].
In order to validate the densitometric measurements the exper-
iment with DOPC:PE at 2:1 M ratio was repeated but phosphorus
contents of TLC spots were quantiﬁed by a chemical (Fiske) method.
Both the densitometry method used above and the TLC+phosphorus
assay led to similar results after 60 min (Table S1). Thus under these
conditions α-toxin can cleave at least one substrate other than PC or
SM, namely PE, in contrast to current opinion. The observation that
cleavage does occur even in the absence of cholesterol also contradicts
previous conclusions made by other authors [32].
In the presence of SM, in LUVs composed of SM:PE:Chol at 2:1:1 M
ratio, α-toxin was also able to hydrolyse PE (Fig. 4). Again at the late
stages of hydrolysis, the proportion of cleaved PE was even higher
than that of SM. Note that in this and other experiments carried out in
the presence of SM, assays were performed at pH=7, at which SMase
activity of CpPLC is optimal [27].
Fig. 2. Docking results. CpPLC residues involved in phospholipids polar head group interaction: D5PC (A), 5SM (B), D5PE (C), D5PG (D), D5PI (E). Hydrogen bonds are represented as
dotted lines.
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substrates, an equimolar PE:PC:SM:Chol mixture was incubated with
the enzyme and the mixture composition determined by quantitative
31P-NMR. This technique has been used successfully in the quantitative
analysis of phospholipidmixtureswithout chromatographic separation,
since it is possible to obtain a separate signal for every phospholipid
class [12,29,30]. The hydrolytic activity of the toxinwas assayed on LUV.
The reaction was stopped after 60 min and the reaction mixture was
quantiﬁed (Fig. 5). DOPGwas used as an external standard. The spectra
revealed the hydrolytic activity of the toxin on the three substrates used
in the following order of preference: DOPC≈PENSM. Thus 31P-NMR
conﬁrms that, at least in the late stages of hydrolysis, CpPLC cleaves PE in
addition to PC and SM, as predicted by the docking studies.3.2.2. Negatively charged phospholipid
Despite the fact that PG is not found in signiﬁcant amounts in
mammalian cell membranes, we checked the hydrolytic activity of the
α-toxin on this phospholipid because of its net charge and the nature of
the polar head group, which is structurally very different from the
choline moiety and its different methylated forms. α-Toxin from
C. perfringens was able to hydrolyse DOPG in the presence of DOPC in
the mixtures: DOPC:DOPG (2:1) (Fig. 6A), DOPC:DOPG (1:1) (Fig. 6B)
and DOPC:DOPG:Chol (2:1:1) (Fig. 6C). In these cases there was a clear
preference for PC over PG, even after long incubation times, in
agreementwith thedockingdifﬁculties found in the in silico experiment.
Chol improves PGhydrolysis in agreementwith previouswork fromour
group [28] where we demonstrated the activating effect of Chol on the
Fig. 3.Hydrolysis of egg phosphatidylethanolamine byα-toxin in the presence of DOPC.
(A) LUVs are composed of DOPC:PE at 2:1 M ratio and (B) DOPC:PE:Chol at 2:1:1 M
ratio. Assays are carried out at 0.3 mM liposome concentration, 20 ng/ml enzyme, in
buffer A at pH 5 and 37 °C. Hydrolysed lipid is quantiﬁed by the TLC+densitometry
method. Mean values±S.D. of four independent experiments. Statistical signiﬁcance
(Student's t-test): *, pb0.05.
Fig. 5. Quantitative 31P-NMR assay of α-toxin activity on LUVs. Representative NMR
spectra showing the chemical shift of the different components of LUVs before (A) and
after 60 min enzyme incubation (B). LUVs are composed of DOPC:SM:PE:Chol at
1:1:1:1 M ratio. DOPG is used as an external standard. Numbers under each lipid
indicate their amount relative to DOPG in that particular assay. Assays are carried out at
5 mM liposome concentration, 334 ng/ml enzyme, in buffer A at pH 5 and 37 °C.
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carried out with LUVs composed of DOPC:DOPG (2:1) were repeated,
and the amounts of the different phospholipids were quantiﬁed with
the TLC+chemical phosphorus assay after 60 min with similar results
(Table S2).
When activities were assayed with DOPG:Chol (2:1) LUV,
detectable amounts of phospholipid were hydrolysed by the toxin
(Fig. 7). Note that in all cases the percentage of cleaved PG is lower
than those found for PC or PE or SM in comparable experiments
(Fig. 3), again in agreement with the in silico observations.Fig. 4. Hydrolysis of egg phosphatidylethanolamine by α-toxin in the presence of SM.
LUVs are composed of SM:PE:Chol at 2:1:1 M ratio. Assays are carried out at 0.3 mM
liposome concentration, 80 ng/ml enzyme, in buffer A at pH 7 and 37 °C. Lipid
hydrolysis is determined by the TLC+densitometry method. Mean values±S.D. of
three independent experiments. Statistical signiﬁcance (Student's t-test): *, pb0.05.As far aswe knew, PI was no substrate for CpPLC. Our previouswork
[28] showed that this lipid has no signiﬁcant effect on the overall
hydrolytic activity ofα-toxin in model membranes. However, the toxin
does hydrolyse liver PI in the presence of DOPC and SM (Table 2), to a
similar extent as its more canonical substrates. PI docking had been
observed to be also very similar to that of PC in the in silico studies.
According to the literature PS is a BcPLC substrate [15,16] and we
were expecting the same for α-toxin. However, the initial docking
results were inconclusive for this lipid. Nevertheless, when we checked
the activity in the presence of DOPC (Fig. 8) or SM (Table 3), indeed a
hydrolytic activity was detected. New docking attempts showed a
competition between the carboxyl and phosphate moieties in the head
group, preventing the docking of the phosphate in the active site.
Although this may be an artifact of the docking parameters, we can
therefore not relate the hydrolytic activity of the toxin on this ligand to
speciﬁc interactions with the head group.
4. Discussion
The main conclusion in this paper is that the phospholipase of
C. perfringens α-toxin, that was believed to cleave only PC and SM,
degrades in fact a wide variety of phospholipids. A number of
considerations are pertinent in the context of this observation.
Fig. 6.Hydrolysis of dioleoylphosphatidylglycerol (DOPG) byα-toxin in the presence of
DOPC. LUVs are composed of DOPC:DOPG at 2:1 M ratio (A), DOPC:DOPG at 1:1 M ratio
(B) and DOPC:DOPG:Chol at 2:1:1 M ratio (C). Assays are carried out at 0.3 mM
liposome concentration, 20 ng/ml enzyme, in buffer A at pH 5 and at 37 °C. The
hydrolysed lipid is quantiﬁed by the TLC+densitometry method. Mean values±S.D. of
three independent experiments. Statistical signiﬁcance (Student's t-test): *, pb0.05;
**, pb0.01.
Fig. 7. Hydrolysis of dioleoylphosphatidylglycerol (DOPG) byα-toxin. LUV composition
is DOPG:Chol at 2:1 M ratio. Assays are carried out at 0.3 mM liposome concentration,
80 ng/ml of enzyme, in buffer A at pH 5 and 37 °C. The lipid hydrolysed is quantiﬁed by
the TLC+densitometry method. Mean values±S.D. of three independent experiments.
Table 2
Hydrolysis of liver phosphatidylinositol (PI) by α-toxin in the presence of DOPC and SM.
Assays are carried out at 1 mM liposome concentration, 66 ng/ml enzymeandpH5 for PLC
activity and 266.6 ng/ml and pH 7 for SMase activity, in buffer A for 30 min at 37 °C. Lipid
hydrolysis is determined by the TLC+densitometry method. Mean values±S.D. of three
independent experiments.
LUV composition Lipid Hydrolysed lipid (mol%)
DOPC:PI:Chol 2:1:1 DOPC 56.1±2.05
Liver PI 46.52±6.1
SM:PI:Chol 2:1:1 SM 24±7
Liver PI 22.2±3.7
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CpPLC is an amphitropic protein, it can exist freely in solution but
binds the membrane in order to exert its biological function [33]. The
hydrolytic phosphodiesterase reaction requires that the phospholipid
headgroup is somehow extracted or isolated from other equivalent
molecules in the bilayer, and accommodated within the active site of
the enzyme. The degree of afﬁnity of the phospholipid headgroup for
the active site will largely control the catalytic efﬁciency. In our study,
a simple bioinformatic tool such as molecular docking has provided
results of high heuristic value, with virtually all the experimental
observations (Figs. 5–9, Table 1) having been anticipated by thecalculations. This in turn provides a ﬁrm basis for further predictions
concerning CpPLC and related phospholipases, and furthermore, for
the development of new speciﬁc enzyme inhibitors and the design of
new drugs. Docking programs ﬁnd their most important applications
in virtual database screening approaches in which hundreds of
thousands of molecules are docked into the binding pocket to identify
plausible binders [34]. The CpPLC has historically been associatedwith
the ability of the bacterium to cause gangrene and gastrointestinal
disease (e.g. food poisoning and necrotic enteritis) in humans,
whereas in other animals gastrointestinal and enterotoxemic diseases
occur more frequently [35,36]. Various workers have investigated the
efﬁciency of a toxoid vaccine in protection against necrotic enteritis
in poultry [37,38]. These results indicated that vaccination with a
C. perfringens type A α-toxoid can help to control losses related to this
disease, but this vaccine it is not a 100% protection against the
bacteria. Therefore, structure-based drug design methods could help
us to design new effective inhibitors for these pathogenic bacteria,
which are becoming of signiﬁcant economic importance worldwide
due to the pathologies it causes in animals.
4.2. Our results in light of previous studies
There is a signiﬁcant, if not extensive, literature concerning CpPLC,
and the number of publications dealing with structurally related
enzymes, e.g. the B. cereus phospholipases C, is already sizeable. Previous
authors have considered that α-toxins, including CpPLC, were devoid of
activity on phospholipids other than PC or SM. Evidently the latter view
must be corrected in the light of the above results.
Not only studies from other laboratories, but also our own require
some reinterpretation. In particular in our recent paper CpPLC activity
wasmeasured onmixtures of PC or SMwith e.g. PE, or PI, and the results
were interpreted as if phospholipids other than PC or SMwould not act
as substrates [28]. However, in light of the results presented here it
appears that, even if the absolute values of enzyme activities may have
Fig. 8. Hydrolysis of dioleoylphosphatidylserine (DOPS) by α-toxin in the presence of
DOPC. LUVs are composed of DOPC:DOPS:Chol at 2:1:1 M ratio. After 1 min incubation,
Ca2+ is added (3 mM ﬁnal concentration). Assays are carried out at 1 mM liposome
concentration, 66 ng/ml enzyme and pH 5, in buffer A for 30 min at 37 °C. Lipid
hydrolysis is determined by the TLC+densitometry method. Mean values±S.D. of
three independent experiments. Statistical signiﬁcance (Student's t-test): **, pb0.01.
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activating the lipase activity while others being inhibitory, or just
neutral, remain fully valid. In addition, the present results conﬁrm and
clarify someobservations and suggestionsmade in our previous studies.
In particular, we had found that the PLC and SMase activities ofα-toxin,
while being obviously located in the same protein, were different
enough (maximum rates, optimum pH, effects of inhibitors/activators)
to suggest that α-toxin would contain two active centers, one for PLC
and one for SMase, partially overlapping in the same region of the
protein [28]. Our molecular docking experiments predict a different
pattern of docking for ceramide-containing molecules than for
glycerolphosphatides, entailing in the former case absence of partici-
pation of residue Y57 for headgroup interaction. This could provide a
simple, testable explanation for the observed results, namely only a
single active site towhich sphingomyelin and phosphatidylcholine bind
in a slightlydifferentway, phosphatidylcholinebindingmore efﬁciently,
thus beinghydrolysedathigher rates. Another possible explanation for a
clear preference for phosphatidylcholine could be found at the
membrane level. Even though both SM and PC have the same polar
head group function, the hydrophobic part of the molecules differ
greatly. The interfacial regions of SM and PC differ signiﬁcantly from
eachother, SMhas the amide group, a freehydroxyl on C3 and the trans-
double bond between C4 and C5 [39]. The amide and hydroxyl groups
can act as hydrogen bond donors and acceptors, whereas the amide
carbonyl in SMonly can act as hydrogen acceptor [40]. PCwith two ester
carbonyls has only hydrogen bond accepting features. These interfacial
differences give SMs the unique ability to form both intra- and
intermolecular hydrogen bonding [41] and therefore more glued to
the bilayer. In a three component bilayer membrane (PC/SM/Chol) in a
NMR study, it was observed that cholesterol interacted more strongly
with SM as compared to PC [42,43]. Such SM propensity to establish
hydrogen bonds with other membrane components may prevent easy
substrate extraction from the membrane for CpPLC or other protein.
However, CpPLC has an extra domain at the C-terminal compared toTable 3
Hydrolysis of dioleoylphosphatidylserine (DOPS) by α-toxin in the presence of SM.
After 1 min incubation, Ca2+ is added (3 mM ﬁnal concentration). Assays are carried
out at 1 mM liposome concentration, 266.6 ng/ml enzyme and pH 7, in buffer A for
30 min at 37 °C. Lipid hydrolysis is determined by the TLC+densitometry method.
Mean values±S.D. of three independent experiments.
LUV composition Lipid Hydrolysed lipid (mol%)
SM:DOPS:Chol 2:1:1 SM 17.8±0.8
DOPS 27.7±6.1BcPLC. CpPLC C-domain is an eight-stranded, antiparallel, β-sandwich
domain, which is an analog of the eukaryotic C2 domains [44] and
removal of this domain reduces, but does not abolish, sphingomyelinase
activity [45,46]. This extra domain might allow the protein to remain in
the membrane for longer periods favoring the SM extraction from the
bilayer. This is a domain absent in BcPLC, as is the SMase activity.
Chol is an important membrane component for the activity of α-
toxin. Nagahama et al. (1996) concluded that the presence of Cholwas
essential forα-toxin-vesicle interaction, and consequently forα-toxin
activity. In pure egg PC monolayers, C. perfringens α-toxin showed a
negligible activity at lateral pressures lower than 30 mN/m compared
to the activity developed by α-toxin in the presence of Chol [31].
However, under our experimental conditions α-toxin was able to
hydrolyse different phospholipids with no Chol in the bilayer. This is
in agreement with our own previous observations [27] in which we
demonstrate the activating effect of cholesterol due to its intrinsic
negative curvature.
In theseexperimentswehave usedphospholipidswithdifferent acyl
chain lengths (see Material and methods), in agreement with previous
experiments [28], and in order to obtain a good andmeasurable activity.
The same principle was applied for the pH and protein concentration
[27,28]. These factorsmight affect the ﬂuidity and packing of the bilayer
and by consequence the toxin activity, which might explain some
differences with previous publications. However, these differences
cannot account for the demonstrated low speciﬁcity of the α-toxin.
4.3. Comparative and adaptive aspects
Numerous bacteria release extracellular toxins with phospholipase
and sphingomyelinase activities. For example,B. cereusproduces at least
twophospholipases C and one sphingomyelinase [13–15], Pseudomonas
aeruginosa produces a multifunctional toxin (PlcH) with phospholipase
C, sphingomyelinase and sphingomyelin synthase activity [12,32,47],
and a L. monocytogenes toxin also exhibits phospholipase and
sphingomyelinase activities [2,10]. These toxins have often pathogenic
relevance. Indeed, C. perfringensα-toxin is themain virulence factor for
gas gangrene in humans, and L. monocytogenes PLC toxin is involved in
the intercellular transfection of the bacteria.
While there is no signiﬁcant sequence homology to known
eukaryotic gene data bases, antibodies raised towards BcPLC cross-
react with proteins in mammalian cells that hydrolyse PC at consider-
able rates [48]. This information along with the fact that these proteins
are not essential for bacterial replication, has led to the suggestion that
these genes come fromhorizontal transfer fromeukaryotic hosts [49]. In
fact, many of these toxins are structurally homologous to mammalian
phospholipases. Their role is basically defense and eukaryotic mem-
brane disruption, in order to obtain nutrients or to scape the phagosome
or endosome. This could be the case for C. perfringens, P. aeruginosa and
L. monocytogenes, to which speciﬁc phospholipase genes might have
been transferred, andhave since lost speciﬁcity. In contrast to previously
published data, α-toxin is able to hydrolyse other phospholipids than
SM and PC in model membranes. This wider substrate speciﬁcity might
allow C. perfringens to infect a greater variety of host tissues of which
membrane composition can differ from one cell type to another.
Moreover, this low speciﬁcity may help to disrupt intracellular
membrane types that vary in composition and help the bacterium to
escape the early phagosome and from the host cell cytoplasm, thus
increasing α-toxin tissue damaging ability.
C. perfringens α-toxin at high concentrations induces massive
degradation of PC and SM in membranes, followed by membrane
disruption. However, small amounts of toxin cause limited hydrolysis of
PC and SM, generating diacylglycerol and ceramide, respectively. These
events activate various signal transduction pathways, which lead to the
uncontrolledproductionof several intercellularmediators as follows. The
toxin causes contractionof isolated rat ileumandaorta tissue through the
activation of phospholipid metabolism in membranes [50,51]. Notably,
2626 P. Urbina et al. / Biochimica et Biophysica Acta 1808 (2011) 2618–2627the toxin activates the arachidonic acid cascade in isolated rat aorta [52].
It was found that the toxin-induced contraction is related to the
production of thromboxane A2 from arachidonic acid. Later, similar
results were reported for PLC produced by other microorganisms [53]. It
is therefore likely that bacterial PLC mimics the actions of endogenous
PLC in eukaryotic cell membranes, demonstrating its relevance as a tool
for the study of eukaryotic signaling pathways.
4.4. Initial enzyme rates and substrate speciﬁcity
The reason why PE, PI, PG, and perhaps other phospholipids have
never been suggested as CpPLC substrates in the past is not obvious and
CpPCL is not the only example. One of our laboratories has recently
reported that PlcHR2, a phospholipase C from P. aeruginosa and totally
unrelated toCpPLC, is not speciﬁc for PC andSMas it hadbeendescribed,
but can also hydrolyse PE, PG or CL [12]. Among the reasons for this
oblivionwe can venture at least two. One is the fact that these enzymes
are often tested with soluble, artiﬁcial substrates, or with natural lipids
in mixed micelles with surfactants, and these conditions are very
different from the physiological situation of an enzyme binding a lipid
bilayer. Alternatively, or perhaps additionally, only the initial stages of
enzyme activity are considered worthy of attention. This is strictly true
for kinetic studieswhenmeasurement of initial rates is required, but not
necessarily for studying other aspects of enzyme behavior. In our case
there are examples, e.g. Fig. 3A, inwhich the presumednon-substrate PE
is only hydrolysed after 10 min, so that its cleavage would be missed
in initial rate measurements. The same happened with P. aeruginosa
PlcHR2, acting on PC/PE mixtures [12]. We conclude that the full
exploration of a given enzyme activity goes well beyond the initial
stages of hydrolysis. It is likely that for the early stages of α-toxin
activity, in which the main effects occur through the generation of lipid
signal diacylglycerol and ceramide, PC and SM are the main substrates.
However, at later stages of α-toxin attack, virtually all membrane
phospholipids can be degraded.
From the structure of the docked complex and by site-directed
mutagenesis of the residues suggested to play roles in the binding to the
substrate head group (D2, G3 and Y57), we could study the modulation
of the selectivity of CpPLC as was successfully done for BcPLC [47].
Moreover, the homology of CpPLC with BcPLC and with the other
members of the bacterial phospholipase C family, gave us the
opportunity to set a paragon for the speciﬁcity of other phospholipases
that have the same motif in their sequence.
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